143 related articles for article (PubMed ID: 19756307)
1. Enhanced levels of mitochondrial enzyme 17beta-hydroxysteroid dehydrogenase type 10 in patients with Alzheimer disease and multiple sclerosis.
Kristofiková Z; Bocková M; Hegnerová K; Bartos A; Klaschka J; Rícný J; Rípová D; Homola J
Mol Biosyst; 2009 Oct; 5(10):1174-9. PubMed ID: 19756307
[TBL] [Abstract][Full Text] [Related]
2. Lateralization of 17beta-hydroxysteroid dehydrogenase type 10 in hippocampi of demented and psychotic people.
Hovorkova P; Kristofikova Z; Horinek A; Ripova D; Majer E; Zach P; Sellinger P; Ricny J
Dement Geriatr Cogn Disord; 2008; 26(3):193-8. PubMed ID: 18765932
[TBL] [Abstract][Full Text] [Related]
3. Neuroinflammation and complexes of 17β-hydroxysteroid dehydrogenase type 10--amyloid β in Alzheimer's disease.
Krištofiková Z; Řípová D; Bartoš A; Bocková M; Hegnerová K; Řičný J; Čechová L; Vrajová M; Homola J
Curr Alzheimer Res; 2013 Feb; 10(2):165-73. PubMed ID: 23463935
[TBL] [Abstract][Full Text] [Related]
4. Multiple functions of type 10 17beta-hydroxysteroid dehydrogenase.
Yang SY; He XY; Schulz H
Trends Endocrinol Metab; 2005; 16(4):167-75. PubMed ID: 15860413
[TBL] [Abstract][Full Text] [Related]
5. Tau protein, phosphorylated tau protein and beta-amyloid42 in the cerebrospinal fluid of multiple sclerosis patients.
Valis M; Talab R; Stourac P; Andrys C; Masopust J
Neuro Endocrinol Lett; 2008 Dec; 29(6):971-6. PubMed ID: 19112391
[TBL] [Abstract][Full Text] [Related]
6. Interactions of 17β-Hydroxysteroid Dehydrogenase Type 10 and Cyclophilin D in Alzheimer's Disease.
Kristofikova Z; Springer T; Gedeonova E; Hofmannova A; Ricny J; Hromadkova L; Vyhnalek M; Laczo J; Nikolai T; Hort J; Petrasek T; Stuchlik A; Vales K; Klaschka J; Homola J
Neurochem Res; 2020 Apr; 45(4):915-927. PubMed ID: 31997103
[TBL] [Abstract][Full Text] [Related]
7. Attenuated antiaggregation effects of magnetite nanoparticles in cerebrospinal fluid of people with Alzheimer's disease.
Gažová Z; Antošová A; Krištofiková Z; Bartoš A; Ríčný J; Cechová L; Klaschka J; Rípová D
Mol Biosyst; 2010 Nov; 6(11):2200-5. PubMed ID: 20721410
[TBL] [Abstract][Full Text] [Related]
8. Harnessing functional plasticity of enzymes: a fluorogenic probe for imaging 17beta-HSD10 dehydrogenase, an enzyme involved in Alzheimer's and Parkinson's diseases.
Froemming MK; Sames D
J Am Chem Soc; 2007 Nov; 129(46):14518-22. PubMed ID: 17958419
[TBL] [Abstract][Full Text] [Related]
9. [Change of fibroblast calcium levels caused by beta-amyloid peptide in Alzheimer disease].
Palotás A; Kálmán J; Laskay G; Juhász A; Janka Z; Penke B
Ideggyogy Sz; 2002 May; 55(5-6):164-7. PubMed ID: 12122875
[TBL] [Abstract][Full Text] [Related]
10. Decrease in age-adjusted cerebrospinal fluid beta-secretase activity in Alzheimer's subjects.
Wu G; Sankaranarayanan S; Tugusheva K; Kahana J; Seabrook G; Shi XP; King E; Devanarayan V; Cook JJ; Simon AJ
Clin Biochem; 2008 Aug; 41(12):986-96. PubMed ID: 18489907
[TBL] [Abstract][Full Text] [Related]
11. Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease.
Wang X; Su B; Perry G; Smith MA; Zhu X
Free Radic Biol Med; 2007 Dec; 43(12):1569-73. PubMed ID: 18037122
[TBL] [Abstract][Full Text] [Related]
12. Detection of myelin basic protein in cerebrospinal fluid.
Ohta M; Ohta K
Expert Rev Mol Diagn; 2002 Nov; 2(6):627-33. PubMed ID: 12465458
[TBL] [Abstract][Full Text] [Related]
13. Hydroxysteroid (17β) dehydrogenase X in human health and disease.
Yang SY; He XY; Miller D
Mol Cell Endocrinol; 2011 Aug; 343(1-2):1-6. PubMed ID: 21708223
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid biomarkers in Alzheimer disease: a fractional improvement?
Galasko D
Arch Neurol; 2003 Sep; 60(9):1195-6. PubMed ID: 12975282
[No Abstract] [Full Text] [Related]
15. Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.
Mattsson N; Axelsson M; Haghighi S; Malmeström C; Wu G; Anckarsäter R; Sankaranarayanan S; Andreasson U; Fredrikson S; Gundersen A; Johnsen L; Fladby T; Tarkowski A; Trysberg E; Wallin A; Anckarsäter H; Lycke J; Andersen O; Simon AJ; Blennow K; Zetterberg H
Mult Scler; 2009 Apr; 15(4):448-54. PubMed ID: 19153172
[TBL] [Abstract][Full Text] [Related]
16. Bri2-23 is a potential cerebrospinal fluid biomarker in multiple sclerosis.
Harris VK; Diamanduros A; Good P; Zakin E; Chalivendra V; Sadiq SA
Neurobiol Dis; 2010 Oct; 40(1):331-9. PubMed ID: 20600910
[TBL] [Abstract][Full Text] [Related]
17. Roles of 17β-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders.
Yang SY; He XY; Isaacs C; Dobkin C; Miller D; Philipp M
J Steroid Biochem Mol Biol; 2014 Sep; 143():460-72. PubMed ID: 25007702
[TBL] [Abstract][Full Text] [Related]
18. Levels of 17β-hydroxysteroid dehydrogenase type 10 in CSF are not a valuable biomarker for multiple sclerosis.
Kristofikova Z; Ricny J; Kaping D; Klaschka J; Kotoucova J; Bartos A
Biomark Med; 2018 Dec; 12(12):1331-1340. PubMed ID: 30520659
[TBL] [Abstract][Full Text] [Related]
19. Intracellular oxidation of allopregnanolone by human brain type 10 17beta-hydroxysteroid dehydrogenase.
He XY; Wegiel J; Yang SY
Brain Res; 2005 Apr; 1040(1-2):29-35. PubMed ID: 15804423
[TBL] [Abstract][Full Text] [Related]
20. Lactic dehydrogenase isoenzymes in adolescents with multiple sclerosis.
Elishkevitz KP; Nussinovitch U; Nussinovitch M
Pediatr Neurol; 2009 Oct; 41(4):259-62. PubMed ID: 19748045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
